Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1011 | 4Aim Societa di Investimento per Azioni a Capitale Fisso (AIM2.MI) | XMIL | IT | 2021-12-31 | 1 week ago | EUR | 250.10 | 370.65 | 148.20% | 26.80 | 10.72% | Ungraded | 0.00 | 0.00% |
| 1012 | 4Aim Societa di Investimento per Azioni a Capitale Fisso (AIM.MI) | XMIL | IT | 2021-12-31 | 2 days ago | EUR | 257.30 | 370.65 | 144.06% | 26.80 | 10.42% | Ungraded | 0.00 | 0.00% |
| 1013 | 4Aim Societa di Investimento per Azioni a Capitale Fisso (4AIM2.MI) | XMIL | IT | 2021-12-31 | 1 year ago | EUR | 281.00 | 370.65 | 131.91% | 26.80 | 9.54% | Ungraded | 0.00 | 0.00% |
| 1014 | Vertex Pharmaceuticals Inc (1VRTX.MI) | XMIL | US | 2023-12-31 | 2 days ago | USD | 0.00 | 135.19 | 0.00% | 34.90 | 0.00% | NCAV (Net-Net) | 34.90 | 0.00% |
| 1015 | BB Biotech AG (BB.MI) | 2019-12-31 | 3 years ago | CHF | 0.00 | 86.11 | 0.00% | 61.25 | 0.00% | NCAV (Net-Net) | 61.25 | 0.00% | ||
| 1016 | Regeneron Pharmaceuticals Inc (1REGN.MI) | XMIL | US | 2023-12-31 | 2 days ago | USD | 0.00 | 508.05 | 0.00% | 113.09 | 0.00% | NCAV (Net-Net) | 113.09 | 0.00% |
| 1017 | EEMS Italia SpA (EEMS.MI) | XMIL | IT | 2022-12-31 | 2 days ago | EUR | 0.20 | 0.00 | 0.00% | 141.71 | 70,855.61% | Ungraded | 0.00 | 0.00% |